Oracle Head and Neck Cancer UK Limited — grant history
Latest income
£648k
Grants listed (FY2024)
0
Listed grants total
—
Accounts grants total
£3k
extracted from its FY2024 accounts
Application guidance — from the funder’s own website
- How to apply: Create an account with us using your email address. Once we have your email address we will give you links to access the appropriate forms for submitting and updating your proposals/applications for funding.
- Deadlines: Applications for the 2024/25 round have now closed and we are not accepting new submissions at this time.
What this funder supports
Causes funded
Where grantees operate
- Cheshire East
- Cheshire West & Chester
- Norfolk
- Throughout England And Wales
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Newcastle University NHS Foundation | FY2023 | £125k | Inequalities project (co-funded with North West Cancer Research) |
| Institute of Cancer Research | FY2023 | £58k | CHK/ AMRC/ Mason Le Page for Koteva |
| Institute of Cancer Research | FY2023 | £53k | AMRC/ Swire Pioneers of Discovery for Fleming and Melake |
| Institute of Cancer Research | FY2023 | £34k | Beaumont/ Terradace for Marsh |
| Institute of Cancer Research | FY2023 | £32k | AMRC for Patin |
| Institute of Cancer Research | FY2023 | £31k | AMRC for Lin |
| Institute of Cancer Research | FY2023 | £26k | AMRC for Cicero/Sala |
| Institute of Cancer Research | FY2023 | £25k | AMRC for Freckleton |
| Institute of Cancer Research | FY2023 | £18k | AMRC for Chan |
| University of Derby NHS Trust | FY2023 | £17k | CHK/ AMRC/ Mason Le Page for Koteva (Note: Note 13 lists this under CHK/AMRC/Mason Le Page, but text links CHK to ICR. However, Note 13 breakdown shows specific amounts. Let's look at Note 13 carefully. The note lists 'CHK/ AMRC/ Mason Le Page for Koteva' with income 38,076 and expenditure (37,500). Wait, the table in Note 13 is complex. Let's re-read Note 13 'Restricted Funds'. It lists specific funds. The 'Balance 31 May 2023' column shows the remaining balance. The 'Expenditure' column shows what was spent. The 'Income' column shows what was received. The question asks for grants PAID OUT. The expenditure column represents the grants paid/charged to the fund. Let's extract the expenditure amounts for the named research funds. |
| University of Derby NHS Trust | FY2023 | £16k | Beaumont/Terradace/AMRC for Patin (Note: Text says Beaumont/Terradace/AMRC for Patin. Note 13 lists 'Beaumont/ Terradace/ AMRC for Patin' with expenditure 22,725? No, let's look at the rows in Note 13 again. The rows are: 'CHK/ AMRC/ Mason Le Page for Koteva', 'AMRC/ Swire Pioneers of Discovery for Fleming and Melake', 'AMRC for Patin', 'Beaumont/Terradace for Marsh', 'AMRC for Lin', 'AMRC for Cicero/Sala', 'AMRC for Freckleton', 'AMRC for Chan', 'Inequalities project', 'University of Southampton for Lola internship', 'Mercers Livery', 'Pennycress Trust'. The columns are Balance 1 June, Transfers, Income, Expenditure, Balance 31 May. The 'Expenditure' column is the grants paid. Let's map them. |
| University of Southampton | FY2023 | £14k | University of Southampton for Lola internship |
| Institute of Cancer Research | FY2023 | £13k | AMRC/ Swire Pioneers of Discovery for Fleming and Melake |
| Institute of Cancer Research | FY2023 | £12k | AMRC for Patin |
| University of Derby NHS Trust | FY2023 | £1k | Pennycress Trust |
| University of Derby NHS Trust | FY2023 | £1k | Mercers Livery |
| Institute of Cancer Research | FY2023 | £1k | AMRC for Cicero/Sala |
| Institute of Cancer Research | FY2023 | £1k | AMRC for Freckleton |
| Institute of Cancer Research | FY2023 | £1k | AMRC for Chan |
| Newcastle University NHS Foundation | FY2023 | £1k | Inequalities project |
| University of Derby NHS Trust | FY2023 | £1k | Beaumont/Terradace for Marsh |
| University of Derby NHS Trust | FY2023 | £1k | CHK/ AMRC/ Mason Le Page for Koteva |
| Swire- Pioneers of Discovery (Fleming and Melake) | FY2022 | £53k | PhD fellows in establishing their careers in the field, while directing more innovative research towards head and neck cancer. |
| Chellaram (Hobart) | FY2022 | £37k | PhD project looking at how medical imaging can be used to predict how likely a head and neck cancer patient is to respond to immunotherapy treatment. |
| Beaumont/Terradace | FY2022 | £34k | Beaumont/Terradace (Marsh) This project intends to understand the lifecycle and development of HPV infections within the mouth to determine how HPV causes head and neck cancer, in order to develop new treatments. |
| Beaumont/ Terradace | FY2022 | £32k | Beaumont/ Terradace (Patin) The aim of this project is to use drugs to make radiation more effective in killing cancer cells, but also to alert the immune system to their presence. |
| AMRC (Patin) | FY2022 | £31k | The work of Daniel Lin will study baseline I DO activity in patients and map this throughout head and neck cancer (HNC) treatment to establish IDO as a biomarker for HNC and support a more personalised therapeutic approach to improve patient outcomes. |
| CHK Charities | FY2022 | £12k | CHK Charities are supporting PhD student, Jennifer Kieselmann, to undertake a cutting edge computationai project at the ICR's Division of Radiotherapy and imaging. |
| AMRC (Lin) | FY2022 | £2k | The work of Daniel Lin will study baseline I DO activity in patients and map this throughout head and neck cancer (HNC) treatment to establish IDO as a biomarker for HNC and support a more personalised therapeutic approach to improve patient outcomes. |
| The Worshipful Company of Mercers | FY2022 | £200 | Funding to support the production of awareness materiais. |
| Pennycress Trust | FY2022 | £200 | Match funded by Pioneers of Discovery fund, supporting PhD fellows. |